Related references
Note: Only part of the references are listed.Continuation rate for asenapine and brexpiprazole treatment in patients with schizophrenia
Yuichi Inoue et al.
BRAIN AND BEHAVIOR (2021)
Japanese Society of Neuropsychopharmacology: Guideline for Pharmacological Therapy of Schizophrenia
Ryota Hashimoto et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2021)
The 12-year trend report of antipsychotic usage in a nationwide claims database derived from four million people in Japan
Takeo Hata et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overview of Its Clinical Efficacy and Safety and a Psychiatrist's Perspective
Yoshinori Watanabe et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder
Mallik Greene et al.
JOURNAL OF MEDICAL ECONOMICS (2018)
A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia
Andy Forbes et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Long-term safety and effectiveness of brexpiprazole in Japanese patients with schizophrenia: A 52-week, open-label study
Jun Ishigooka et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2018)
Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia in Japan: A 6-week, randomized, double-blind, placebo-controlled study
Jun Ishigooka et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2018)
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
Dawn I. Velligan et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients A Systematic Review
Sainza Garcia et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Overview of short- and long-termtolerability and safety of brexpiprazole in patients with schizophrenia
John M. Kane et al.
SCHIZOPHRENIA RESEARCH (2016)
Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies
Christoph U. Correll et al.
SCHIZOPHRENIA RESEARCH (2016)
Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial
Christoph U. Correll et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Psychotropic dose equivalence in Japan
Toshiya Inada et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2015)
A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
John M. Kane et al.
SCHIZOPHRENIA RESEARCH (2015)
Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
Kenji Maeda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
Kenji Maeda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
A Systematic Review and Meta-Analysis of Recovery in Schizophrenia
Erika Jaaskelainen et al.
SCHIZOPHRENIA BULLETIN (2013)
The cost of relapse and the predictors of relapse in the treatment of schizophrenia
Haya Ascher-Svanum et al.
BMC PSYCHIATRY (2010)
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
Gunnar Morken et al.
BMC PSYCHIATRY (2008)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Relapse in schizophrenia: costs, clinical outcomes and quality of life
S Almond et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Share Paper
